These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23518771)

  • 41. Etoposide-loaded biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (epsilon caprolactone) copolymeric micelles as drug delivery vehicle for cancer therapy.
    Mohanty AK; Dilnawaz F; Mohanty C; Sahoo SK
    Drug Deliv; 2010 Jul; 17(5):330-42. PubMed ID: 20370380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes.
    Chang-Lin JE; Burke JA; Peng Q; Lin T; Orilla WC; Ghosn CR; Zhang KM; Kuppermann BD; Robinson MR; Whitcup SM; Welty DF
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4605-9. PubMed ID: 21421864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of polymeric poly(epsilon-caprolactone) injectable implant delivery system for the controlled delivery of contraceptive steroids.
    Dhanaraju MD; Gopinath D; Ahmed MR; Jayakumar R; Vamsadhara C
    J Biomed Mater Res A; 2006 Jan; 76(1):63-72. PubMed ID: 16108044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Control of filtering bleb structure through tissue bioengineering: An animal model.
    Chen HS; Ritch R; Krupin T; Hsu WC
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5310-4. PubMed ID: 17122118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of alkoxylphenacyl-based polycarbonates as a potential platform for controlled delivery of a model anti-glaucoma drug.
    Manickavasagam D; Wehrung D; Chamsaz EA; Sanders M; Bouhenni R; Crish SD; Joy A; Oyewumi MO
    Eur J Pharm Biopharm; 2016 Oct; 107():56-66. PubMed ID: 27320697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biocompatibility and drug release behavior of chitosan/poly (vinyl alcohol) corneal shield in vivo.
    Li GX; Gu X; Song HY; Nan KH; Chen H
    Int J Clin Exp Med; 2015; 8(8):12949-55. PubMed ID: 26550213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Poly(L-lysine) and Heparin Coatings on the Surface of Polyester-Based Particles on Prednisolone Release and Biocompatibility.
    Mohamed A; Korzhikov-Vlakh V; Zhang N; Said A; Pilipenko I; Schäfer-Korting M; Zoschke C; Tennikova T
    Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34072016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The SPOTS System: An Ocular Scoring System Optimized for Use in Modern Preclinical Drug Development and Toxicology.
    Eaton JS; Miller PE; Bentley E; Thomasy SM; Murphy CJ
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):718-734. PubMed ID: 29239680
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Blemish Formation in Processed Microfilm II.
    Pope CI
    J Res Natl Bur Stand A Phys Chem; 1970; 74A(1):31-36. PubMed ID: 32523168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patents In Miniature: The Effects of Microfilm as an Information Technology, 1938-68.
    Bellido J
    Technol Cult; 2023; 64(2):407-433. PubMed ID: 38588234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microfilm magic.
    GREEN PD
    Sci Am; 1947 Aug; 177(2):60-3. PubMed ID: 20252588
    [No Abstract]   [Full Text] [Related]  

  • 52. Microfilms in relation to reference service.
    SEIDELL A
    Bull Med Libr Assoc; 1951 Jul; 39(3):203-5. PubMed ID: 14848626
    [No Abstract]   [Full Text] [Related]  

  • 53. Electronic channel fringe holography for depth and delay measurements.
    Iglesias I; Chen HS; Mills KD; Dilworth DS; Leith EN
    Appl Opt; 1999 Apr; 38(11):2196-203. PubMed ID: 18319781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Heart disease discovered on chest microfilms.
    SLATTERY RV
    J Am Med Assoc; 1953 Aug; 152(17):1595-6. PubMed ID: 13069222
    [No Abstract]   [Full Text] [Related]  

  • 55. Targeting Ocular Drug Delivery: An Examination of Local Anatomy and Current Approaches.
    Dosmar E; Walsh J; Doyel M; Bussett K; Oladipupo A; Amer S; Goebel K
    Bioengineering (Basel); 2022 Jan; 9(1):. PubMed ID: 35049750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia.
    Singh RB; Liu L; Yung A; Anchouche S; Mittal SK; Blanco T; Dohlman TH; Yin J; Dana R
    Ocul Surf; 2021 Jul; 21():66-77. PubMed ID: 34000363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanotechnology for the Treatment of Allergic Conjunctival Diseases.
    Liu YC; Lin MT; Ng AHC; Wong TT; Mehta JS
    Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33138064
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue Responses and Wound Healing following Laser Scleral Microporation for Presbyopia Therapy.
    Liu YC; Hall B; Lwin NC; Teo EPW; Yam GHF; Hipsley A; Mehta JS
    Transl Vis Sci Technol; 2020 Mar; 9(4):6. PubMed ID: 32818094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis.
    Tagalakis AD; Madaan S; Larsen SD; Neubig RR; Khaw PT; Rodrigues I; Goyal S; Lim KS; Yu-Wai-Man C
    J Nanobiotechnology; 2018 Nov; 16(1):97. PubMed ID: 30482196
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a Sustained-Release Prednisolone Acetate Biodegradable Subconjunctival Implant in a Non-Human Primate Model.
    Liu YC; Ng AHC; Ng XW; Yan P; Venkatraman SS; Mehta JS; Wong TT
    Transl Vis Sci Technol; 2017 Sep; 6(5):9. PubMed ID: 29046829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.